RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Revenue growth (%)

BrightPath Biotherapeutics Co., Ltd.【JP:4594】

Market cap
¥6.3B
P/E ratio
-5.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20251,473.6-1593.93%
Mar 31, 2024-98.6+50.07%
Mar 31, 2023-65.7-112.75%
Mar 31, 2022515.3-762.05%
Mar 31, 2021-77.8-16.08%
Mar 31, 2020-92.7+65.51%
Mar 31, 2019-56+69.41%
Mar 31, 2018-33.1-7.10%
Mar 31, 2017-35.6-32472.73%
Mar 31, 20160.1-100.92%
Mar 31, 2015-12-111.22%
Mar 31, 2014106.7-19.00%
Mar 31, 2013131.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)